Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2012 | 12-2011 | |
| Sales | 1,999 | 0 |
| Cost of Goods | 860 | N/A |
| Gross Profit | 1,139 | N/A |
| Operating Expenses | 5,915 | 0 |
| Operating Income | -3,916 | N/A |
| Interest Expense | 56 | 0 |
| Other Income | -12 | 0 |
| Pre-tax Income | -3,984 | 0 |
| Net Income Continuous | -3,984 | N/A |
| Net Income | $-3,984 | $N/A |
| EPS Basic Total Ops | -4.20 | N/A |
| EPS Basic Continuous Ops | -3.19 | N/A |
| EPS Diluted Total Ops | -4.20 | N/A |
| EPS Diluted Continuous Ops | -3.19 | N/A |
| EBITDA(a) | $-3,772 | $N/A |